US Patent 11884939 Vaccinia virus mutants useful for cancer immunotherapy
Patent 11884939 was granted and assigned to Memorial Sloan Kettering Cancer Center on January, 2024 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
December 29, 2021
0
Date of Patent
January 30, 2024
0
Patent Applicant
Patent Application Number
17565332
0
Patent Citations
•••
Patent Inventor Names
Taha Merghoub
0
Ning Yang
0
Liang Deng
0
Stewart Shuman
0
Jedd Wolchok
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 11884939 Vaccinia virus mutants useful for cancer immunotherapy
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
